A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers

Completed · Not applicable

Conditions studied: Tobacco Use Disorder, Head and Neck Neoplasms, Thoracic Neoplasms, Radiation

In brief

Smoking is the greatest risk factor for upper aerodigestive cancers (thoracic or head and neck) and negatively impacts survival and other outcomes, but many patients have difficulty quitting after their diagnosis. Smoking cessation interventions for cancer patients thus far have had limited success. This is a pilot randomized controlled trial designed to determine if a new comprehensive, evidence-based smoking cessation intervention can improve quit rates for cancer patients who smoke.

Key facts

Study ID

NCT02188563

Run by

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

People needed

30

Starts

2014-05-01

Expected to finish

2016-05-01

Last updated by the study team

2019-01-17

Who can join

Age: 18 and older, up to 105. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• New diagnosis of head and neck or thoracic (including lung) cancer
• Undergoing radiation at Johns Hopkins Radiation Oncology for 5 or more weeks
• English-speaking and able to provide informed consent
• Smoked any cigarettes in previous 14 days

You may not qualify if…

• Palliative radiation
• Undergoing stereotactic radiosurgery
• Pregnant or breastfeeding

Where it is running

• Johns Hopkins Medicine — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.